JENNIFER BELL: Open Payments
NPI 1811340169 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 27 payments from 7 companies in 2025. Trend: 2023 $1,383 · 2024 $701 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $162 |
| AstraZeneca Pharmaceuticals LP | 4 | $96 |
| PFIZER INC. | 5 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Amgen Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
Products named: Ozempic, FARXIGA, Rybelsus, JARDIANCE, NURTEC ODT, OTEZLA, PREVNAR 20, GARDASIL 9.
Industry payments across NY — which companies pay providers there.
